Kesuting Syrup in the Treatment of Corona Virus Disease 2019 (COVID-19)
Clinical trial NCT05366231 · COMPLETED
Trial details
- NCT number
- NCT05366231
- Sponsor
- Guizhou Bailing Group Pharmaceutical Co Ltd
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-08
- Primary completion
- 2022-09-15
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.